Third quarter 2026 total revenues of $80.9 million, including net product sales of $72.3 million and contract revenues from ...

First presentation at a scientific conference of key data from RECLAIM, a multicenter Phase 2 trial of a balanced 1:1 glucagon/GLP-1 receptor ...

Ramayana Movie Review 2026: Ranbir Kapoor and Yash's much-awaited mythological film Ramayana, directed by Nitesh Tiwari, has ...

Nitesh Tiwari’s Ramayana: Part 1 has opened to widespread acclaim worldwide. Early viewers are praising its visual grandeur, ...

The 1990s was a huge era for gaming, and these four games showcase how far games had come graphically even today.

Safety profile presented at ASN Kidney Week 2026 across 29 autoimmune patients treated with a single dose of FT819 and fludarabine-free, ...

The 2026 animated adaptation of 'The Cat in the Hat' brings Dr. Seuss's iconic trickster back to movie screens as an ...

Pivotal results from the Phase 3 TRIUMPH-1 and TRIUMPH-4 trials showed retatrutide delivered substantial reductions in knee ...

Paradigm-shifting phase 3 trial data show that B-cell modulating therapies are having remarkable effects in IgA nephropathy.

CEO Frank Gleeson and Chief Medical Officer Wildon Farwell will speak at 8 a.m. ET Nov. 6; slides are available with the ...

NEW YORK, NY / ACCESS Newswire / November 5, 2026 / INNODATA INC. (Nasdaq:INOD) today reported results for the third quarter ended September 30, 2026. Revenue of $95.6 million, representing 53% ...